0.8082
+0.0572
+(7.62%)
At close: January 10 at 4:00:02 PM EST
0.8198
+0.01
+(1.44%)
After hours: January 10 at 6:55:10 PM EST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -0.18 | -0.38 | -0.89 | -2.06 |
| Low Estimate | -0.18 | -0.38 | -0.89 | -2.06 |
| High Estimate | -0.18 | -0.38 | -0.89 | -2.06 |
| Year Ago EPS | -0.38 | -0.28 | -1.15 | -0.89 |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | 1 | 3 | 3 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
| Currency in USD | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
|---|---|---|---|---|
| EPS Est. | -0.26 | -0.24 | -0.28 | -0.23 |
| EPS Actual | -0.38 | -0.28 | -0.26 | -0.17 |
| Difference | -0.12 | -0.04 | 0.02 | 0.06 |
| Surprise % | -46.15% | -16.67% | 7.14% | 26.09% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.18 | -0.38 | -0.89 | -2.06 |
| 7 Days Ago | -0.21 | -0.43 | -0.98 | -2.24 |
| 30 Days Ago | -0.21 | -0.43 | -0.98 | -2.24 |
| 60 Days Ago | -0.21 | -0.43 | -0.98 | -2.24 |
| 90 Days Ago | -0.21 | -0.43 | -0.98 | -2.24 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | 1 | 1 |
| Up Last 30 Days | 1 | 1 | 1 | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ACXP | 52.63% | -35.71% | 22.61% | -131.46% |
| S&P 500 | 8.70% | 11.55% | 14.03% | 13.42% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 1/10/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 12/10/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 11/14/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 8/12/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 5/16/2024 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 3/19/2024 |
Related Tickers
ALLR Allarity Therapeutics, Inc.
1.0400
-2.80%
GDTC CytoMed Therapeutics Limited
2.7600
+20.52%
WINT Windtree Therapeutics, Inc.
0.2552
-5.09%
AEON AEON Biopharma, Inc.
0.1856
-2.37%
QNRX Quoin Pharmaceuticals, Ltd.
0.6215
-0.26%
SNSE Sensei Biotherapeutics, Inc.
0.5125
-3.30%
ADTX Aditxt, Inc.
0.1699
+1.01%
LIPO Lipella Pharmaceuticals Inc.
2.9000
-8.52%
CYCC Cyclacel Pharmaceuticals, Inc.
0.4199
+1.21%
NLSP NLS Pharmaceutics AG
2.3200
-3.73%